We’re pleased to see an acknowledgement of the need for safety netting, especially as changes are currently being made to the referral criteria for post-menopausal bleeding whilst on HRT. These changes are being done to reduce the volume of referrals being sent to secondary care for investigation and to improve overall waiting times for gynaecological cancer.. This also needs to occur alongside GP training on Gateway C, so GPs know how to refer to vague cancer symptom pathways and rapid diagnostic centres. We also need to move away from the patients representing with unresolved symptoms over periods of months and sometimes years , without testing for cancer. We hear too many stories of misdiagnoses and poor experiences from our clients and through Claire’s Campaign.
- Recommendation 12: The Cancer Network and the cancer arm of the Planned Care Recovery Programme should formally merge to create a single team responsible for setting the strategic direction of cancer care in Wales and directing improvement activities to support this, led by a senior clinician and senior managerial lead, reporting to the Managing Director of the proposed Performance and Productivity Unit and the National Medical Director.
We hope this approach will lead to greater, more consistent and productive engagement with the third sector and greater clarity and accountability within the NHS Exec concerning roles and responsibilities for cancer service guidance and delivery.
- Recommendation 13: Digital Health and Care Wales (DHCW) should develop a plan to begin collecting and publishing more granular tumour-level performance from the beginning of the 2026/27 financial year at the latest.
We expect this data to include the collection and publication of ethnicity data, as our insight revealed this is captured for as little as 15% of patients in some health boards. We want this data to be available to the third sector, in particular those charities providing services to the NHS.